SOPHiA GENETICS SA Debt to Equity Ratio 2020-2025 | SOPH
Current and historical debt to equity ratio values for SOPHiA GENETICS SA (SOPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. SOPHiA GENETICS SA debt/equity for the three months ending March 31, 2025 was 0.16.
| SOPHiA GENETICS SA Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.06B | $0.09B | 0.71 |
| 2024-12-31 | $0.06B | $0.10B | 0.61 |
| 2024-09-30 | $0.06B | $0.11B | 0.57 |
| 2024-06-30 | $0.06B | $0.12B | 0.49 |
| 2024-03-31 | $0.05B | $0.13B | 0.36 |
| 2023-12-31 | $0.06B | $0.15B | 0.36 |
| 2023-09-30 | $0.05B | $0.16B | 0.30 |
| 2023-06-30 | $0.05B | $0.17B | 0.30 |
| 2023-03-31 | $0.05B | $0.19B | 0.26 |
| 2022-12-31 | $0.04B | $0.20B | 0.22 |
| 2022-09-30 | $0.05B | $0.21B | 0.22 |
| 2022-06-30 | $0.05B | $0.23B | 0.22 |
| 2022-03-31 | $0.05B | $0.25B | 0.18 |
| 2021-12-31 | $0.05B | $0.28B | 0.16 |
| 2021-09-30 | $0.05B | $0.29B | 0.16 |
| 2021-06-30 | $0.03B | $0.07B | 0.46 |
| 2021-03-31 | $0.03B | $0.08B | 0.36 |
| 2020-12-31 | $0.03B | $0.10B | 0.31 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.03B | $0.02B | 1.32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.190B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.774B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
| Schrodinger (SDGR) | United States | $1.563B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Omnicell (OMCL) | United States | $1.322B | 23.33 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Standard BioTools (LAB) | United States | $0.350B | 0.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |